By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

RedHill Biopharma Ltd. 

21 Ha’arba’a Street

Tel-Aviv    64739  Israel
Phone: 972-0-3-541-3131 Fax: 972-0-3-541-3144


SEARCH JOBS


Industry
Pharmaceutical






Company News
RedHill Biopharma (RDHL) Receives Notice Of Allowance For A New U.S. Patent Covering Its Combination Therapy For Hard-To-Treat Cancers 9/18/2017 8:28:44 AM
RedHill Biopharma (RDHL) Initiates Promotion Of Esomeprazole Strontium Delayed-Release Capsules 49.3 Mg In The U.S. 9/13/2017 6:40:07 AM
RedHill Biopharma (RDHL) Announces U.S. Commercialization Agreement For FDA-Approved GI Product Esomeprazole Strontium Delayed-Release Capsules 8/17/2017 8:01:02 AM
RedHill Biopharma (RDHL) Provides 2017 Semi-Annual Business Update 8/10/2017 12:28:08 PM
RedHill Biopharma (RDHL) Announces Unanimous Positive DSMB Recommendation For Continuation Of The Phase III Study With RHB-104 For Crohn’s Disease 7/31/2017 11:00:43 AM
RedHill Biopharma (RDHL) Reports 2017 Second Quarter Financial Results 7/25/2017 11:39:54 AM
RedHill Biopharma (RDHL) To Host Second Quarter 2017 Financial Results Conference Call On July 25, 2017 7/18/2017 7:18:20 AM
RedHill Biopharma (RDHL) Announces Last Patient Visit In BEKINDA Phase II Study For IBS-D 7/17/2017 10:30:16 AM
RedHill Biopharma (RDHL) Announces Expected Timeline For DSMB Meeting And Provides Update On Enrollment In The RHB-104 Phase III Study For Crohn’s Disease 7/12/2017 10:29:00 AM
RedHill Biopharma (RDHL) Announces Expected Timeline For DSMB Meeting And Provides Update On Enrollment In The RHB-104 Phase III Study For Crohn’s Disease 7/12/2017 9:06:33 AM
12345678910...
//-->